• Home
  • Search Results
  • Reduction of lipid peroxidation products and advanced glycation end-product precursors by cyanobacterial aldo-keto reductase AKR3G1—a founding member of the AKR3G subfamily.

Reduction of lipid peroxidation products and advanced glycation end-product precursors by cyanobacterial aldo-keto reductase AKR3G1—a founding member of the AKR3G subfamily.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2014-11-08)
Jan Hintzpeter, Hans-Joerg Martin, Edmund Maser
ABSTRACT

The purpose of this study was to investigate the origin and function of the aldo-keto reductase (AKR) superfamily as enzymes involved in the detoxification of xenobiotics. We used the cyanobacterium Synechocystis sp. PCC 6803 as a model organism and sequence alignments to find bacterial AKRs with highest identity to human enzymes. Disappearance of NADPH was monitored spectrophotometrically to calculate enzymatic activity. The molecular weight of the native protein was determined by size exclusion chromatography. Substrate docking was performed by SwissDock. Sequence alignments identified the NADPH-dependent AKR3G1 having 41.5 and 40% identity with the human enzymes AKR1B1 and AKR1B10, respectively. Highest enzymatic efficiency was observed with 4-oxonon-2-enal (4-ONE; k(cat)/K(m), 561 s(-1) mM(-1)) and 4-hydroxynonenal (k(cat)/K(m), 26.5 s(-1) mM(-1)), respectively. P74308 is the most efficient enzyme for 4-ONE discovered until now. Cooperativity of this monomeric enzyme was observed with some substrates. Enzyme inactivation or oligomerization as possible explanations for nonhyperbolic enzyme kinetics were ruled out by Selwyn's test and gel filtration. The role of the little investigated carbonyl-reducing enzymes in detoxification seems to be in fact a very old process with rarely observed nonhyperbolic enzyme kinetics as an adaptation mechanism to higher concentrations of reactive oxygen species.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Butyraldehyde, ≥99.0%, dry
USP
Indomethacin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Indomethacin, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
Coumarin, ≥99% (HPLC)
Sigma-Aldrich
DL-Glyceraldehyde, ≥90% (GC)
Supelco
Flufenamic acid, analytical standard, for drug analysis
Sigma-Aldrich
5-Hydroxymethyl-2-furaldehyde, 99%
Sigma-Aldrich
Glyoxal solution, for molecular biology, BioReagent, ~40% in H2O (~8.8 M)
Sigma-Aldrich
Crotonaldehyde, mixture of cis and trans, ratio of cis- and trans-isomers (~1:20), ≥99.5% (GC)
Supelco
4-Nitrobenzaldehyde, for spectrophotometric det. of amino sugars, ≥99.0%
Coumarin, primary reference standard
Supelco
Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material
Coumarin, European Pharmacopoeia (EP) Reference Standard
Supelco
Furfural, analytical standard
Indomethacin, European Pharmacopoeia (EP) Reference Standard
Supelco
5-(Hydroxymethyl)furfural, analytical standard
Sigma-Aldrich
Furfural, ACS reagent, 99%
Sigma-Aldrich
4-Pyridinecarboxaldehyde, 97%
Sigma-Aldrich
5-(Hydroxymethyl)furfural, ≥99%, FG
Sigma-Aldrich
Glyoxal solution, 40 wt. % in H2O
Sigma-Aldrich
Butyraldehyde, natural, FG
Sigma-Aldrich
4-Nitrobenzaldehyde, 98% (GC)
Sigma-Aldrich
Crotonaldehyde, predominantly trans, ≥99%, contains 0.1-0.2% BHT as stabilizer, 1% H2O as stabilizer
Sigma-Aldrich
Cinnamaldehyde, natural, ≥95%, FG
Sigma-Aldrich
Butyraldehyde, ≥96.0%
Sigma-Aldrich
Pyruvaldehyde solution, 40 wt. % in H2O
Sigma-Aldrich
Butyraldehyde, purified by redistillation, ≥99.5%
Sigma-Aldrich
Furfural, 99%
Sigma-Aldrich
Coumarin, ≥98%
Sigma-Aldrich
Furfural, natural, ≥98%, FCC, FG